Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements (Tables)

v3.22.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Summary of Fair Value of Financial Instruments at Carrying and Fair Value The carrying amount of borrowings outstanding under the Credit Facility approximates fair value as the borrowings bear interest at variable rates and are reflective of market rates. The following table presents the principal amounts of the Company’s Second Lien Notes and Senior Unsecured Notes with the fair values measured using quoted secondary market trading prices which are designated as Level 2 within the valuation hierarchy. See “Note 7 - Borrowings” for further discussion.
December 31, 2021 December 31, 2020
Principal Amount Fair Value Principal Amount Fair Value
(In thousands)
6.25% Senior Notes
$—  $—  $542,720  $344,627 
6.125% Senior Notes
460,241  455,639  460,241  260,036 
9.00% Second Lien Notes
319,659  343,633  516,659  470,160 
8.25% Senior Notes
187,238  184,429  187,238  100,172 
6.375% Senior Notes
320,783  309,556  320,783  161,995 
8.00% Senior Notes
650,000  663,000  —  — 
Total $1,937,921  $1,956,257  $2,027,641  $1,336,990 
Fair Value of Assets Measured on Recurring Basis
The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 and 2020:
December 31, 2021
Level 1 Level 2 Level 3
(In thousands)
Assets
Commodity derivative instruments $—  $1,798  $— 
Contingent consideration arrangements —  20,833  — 
Liabilities
Commodity derivative instruments (1)
—  (172,386) — 
Contingent consideration arrangements —  (25,000) — 
Total net assets (liabilities) $—  ($174,755) $— 
December 31, 2020
Level 1 Level 2 Level 3
(In thousands)
Assets
Commodity derivative instruments $—  $921  $— 
Contingent consideration arrangements —  1,816  — 
Liabilities
Commodity derivative instruments (2)
—  (97,060) — 
Contingent consideration arrangements —  (8,618) — 
September 2020 Warrants —  —  (79,428)
Total net assets (liabilities) $—  ($102,941) ($79,428)
(1)    Includes approximately $2.9 million of deferred premiums which will be paid as the applicable contracts settle.
(2)    Includes approximately $11.2 million of deferred premiums which will be paid as the applicable contracts settle.
Fair Value of Liabilities Measured on Recurring Basis
The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 and 2020:
December 31, 2021
Level 1 Level 2 Level 3
(In thousands)
Assets
Commodity derivative instruments $—  $1,798  $— 
Contingent consideration arrangements —  20,833  — 
Liabilities
Commodity derivative instruments (1)
—  (172,386) — 
Contingent consideration arrangements —  (25,000) — 
Total net assets (liabilities) $—  ($174,755) $— 
December 31, 2020
Level 1 Level 2 Level 3
(In thousands)
Assets
Commodity derivative instruments $—  $921  $— 
Contingent consideration arrangements —  1,816  — 
Liabilities
Commodity derivative instruments (2)
—  (97,060) — 
Contingent consideration arrangements —  (8,618) — 
September 2020 Warrants —  —  (79,428)
Total net assets (liabilities) $—  ($102,941) ($79,428)
(1)    Includes approximately $2.9 million of deferred premiums which will be paid as the applicable contracts settle.
(2)    Includes approximately $11.2 million of deferred premiums which will be paid as the applicable contracts settle.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
The following table presents a reconciliation of the change in the fair value of the liability related to the September 2020 Warrants, which was designated as Level 3 within the valuation hierarchy, for the years ended December 31, 2021 and 2020.
Years Ended December 31,
2021 2020
(In thousands)
Beginning of period $79,428  $— 
Recognition of issuance date fair value —  23,909 
(Gain) loss on changes in fair value (1)
55,390  55,519 
Transfers into (out of) Level 3 (134,818) — 
End of period $—  $79,428 
(1)    Included in “(Gain) loss on derivative contracts” in the consolidated statements of operations.